Microbiology & Infectious Diseases

Only 18 asymptomatic H5N1 cases have been reported globally; most found via enhanced surveillance of high-risk contacts.

These findings highlight that lenacapavir and bNAbs can maintain high rates of virologic suppression while presenting a low risk of resistance.

Global Chagas disease cases decline, yet prevalence grows in non-endemic countries due to migration, new study shows.

Gut bacteria influence HIV reservoir size and activity differently across GI segments, offering insights for targeted cure strategies.

HCV incidence among people who inject drugs in Scotland has halved since 2015, bringing WHO elimination targets within reach.

A new two-dose Salmonella Paratyphi A vaccine offers 73% protection in adults and shows strong safety and immune responses, addressing a major public health need.

Study of 2,061 infants reveals RSV, HMPV, influenza, and viral co-infections significantly increase severe lower respiratory illness risk.

Children face over twice the risk of paediatric long COVID after SARS-CoV-2 reinfection, highlighting urgent needs for prevention.